Cargando…

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function

In an effort to clear persistent HIV infection and achieve a durable therapy-free remission of HIV disease, extensive pre-clinical studies and early pilot clinical trials are underway to develop and test agents that can reverse latent HIV infection and present viral antigen to the immune system for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garrido, Carolina, Spivak, Adam M., Soriano-Sarabia, Natalia, Checkley, Mary Ann, Barker, Edward, Karn, Jonathan, Planelles, Vicente, Margolis, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030263/ https://www.ncbi.nlm.nih.gov/pubmed/27708642 http://dx.doi.org/10.3389/fimmu.2016.00356

Ejemplares similares

Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents
por: Sorensen, Eric S., et al.
Publicado: (2020)

HIV-1 Latency and Latency Reversal: Does Subtype Matter?
por: Sarabia, Indra, et al.
Publicado: (2019)

Janus kinase inhibition suppresses PKC-induced cytokine release without affecting HIV-1 latency reversal ex vivo
por: Spivak, Adam M., et al.
Publicado: (2016)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
por: Lewis, Catherine A., et al.
Publicado: (2023)

HIV Latency in Myeloid Cells: Challenges for a Cure
por: Chitrakar, Alisha, et al.
Publicado: (2022)

Latency reversal plus natural killer cells diminish HIV reservoir in vivo
por: Kim, Jocelyn T., et al.
Publicado: (2022)

Cleavage and Polyadenylation Specificity Factor 6 Is Required for Efficient HIV-1 Latency Reversal
por: Zheng, Yue, et al.
Publicado: (2021)

Latency Reversing Agents: Kick and Kill of HTLV-1?
por: Schnell, Annika P., et al.
Publicado: (2021)

Impact of latency‐reversing agents on human macrophage physiology
por: Hany, Laurent, et al.
Publicado: (2022)

Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
por: Kauder, Steven E., et al.
Publicado: (2009)

The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
por: Clutton, G., et al.
Publicado: (2016)

Long non-coding RNAs and latent HIV – A search for novel targets for latency reversal
por: Trypsteen, Wim, et al.
Publicado: (2019)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
por: Clutton, Genevieve Tyndale, et al.
Publicado: (2018)

NSC95397 is a Novel HIV Latency Reversing Agent
por: Nichols Doyle, Randilea, et al.
Publicado: (2023)

Corrigendum: The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
por: Clutton, G., et al.
Publicado: (2016)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

HIV‐1‐induced type I IFNs promote viral latency in macrophages
por: Dickey, Laura L., et al.
Publicado: (2022)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
por: Bricker, Katherine M., et al.
Publicado: (2021)

Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal
por: Basukala, Binita, et al.
Publicado: (2023)

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2019)

A new BET on the control of HIV latency
por: Karn, Jonathan
Publicado: (2013)

Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors
por: Furtado Milão, Joana, et al.
Publicado: (2022)

Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIV
por: Ghofrani, Joshua, et al.
Publicado: (2023)

Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
por: Alvarez-Carbonell, David, et al.
Publicado: (2017)

Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens
por: Hashemi, Pargol, et al.
Publicado: (2019)

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
por: Delagrèverie, Héloïse M., et al.
Publicado: (2016)

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents
por: Marsden, Matthew D., et al.
Publicado: (2018)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the Long Terminal Repeat
por: Viglianti, Gregory A., et al.
Publicado: (2021)

Bioactive Compounds from Euphorbia usambarica Pax. with HIV-1 Latency Reversal Activity
por: Tsai, Yu-Chi, et al.
Publicado: (2021)

Control of HIV Latency by Epigenetic and Non-Epigenetic Mechanisms
por: Mbonye, Uri, et al.
Publicado: (2011)

Peripheral Vγ9Vδ2 T Cells Are a Novel Reservoir of Latent HIV Infection
por: Soriano-Sarabia, Natalia, et al.
Publicado: (2015)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents
por: Gupta, Vipul, et al.
Publicado: (2018)

Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells
por: Boucau, Julie, et al.
Publicado: (2020)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
por: Taylor, Jared P., et al.
Publicado: (2020)

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling
por: Li, Shifei, et al.
Publicado: (2023)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
por: Li, Rui, et al.
Publicado: (2023)

Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model
por: White, Cory H., et al.
Publicado: (2016)

Biogenesis of P-TEFb in CD4(+) T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways
por: Mbonye, Uri, et al.
Publicado: (2021)

HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency
por: Llewellyn, George N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4tiijrlisuntg8f1havn640anm